Results 131 to 140 of about 365,351 (311)

ACE inhibitors – angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

open access: yesOpen Access Emergency Medicine, 2010
T S Mohamed Saleem1, K Bharani1, K Gauthaman21Department of Pharmacology, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa Dist, Andhra Pradesh, India; 2Department of Drug Technology, Higher Institute of Medical Technology, Derna, LibyaAbstract:
T S Mohamed Saleem   +2 more
doaj  

Blockade of the renin-angiotensin system [PDF]

open access: yes, 2002
The renin-angiotensin-aldosterone system plays a key role in the regulation of fluid and electrolyte balance. Angiotensin-converting enzyme inhibitors inhibit angiotensin-converting enzyme and have been shown to be effective in many cardiovascular ...
Cheung, BMY
core  

The Prognostic Impact of Multiple Adverse Events on Long‐Term Mortality Following Acute Myocardial Infarction

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Adverse events after acute myocardial infarction (AMI) are individually associated with poor outcomes, but the prognostic impact of the overlap of different event types occurring sequentially within the same patient remains uncertain.
Kyung Hoon Roh   +12 more
wiley   +1 more source

Angiotensin II—Real-Life Use and Literature Review

open access: yesMedicina
Angiotensin II is a recently introduced vasopressor, which has been available since 2017. The novelty and the relatively high cost of angiotensin II currently limit its broader application.
Andreja Möller Petrun, Andrej Markota
doaj   +1 more source

Mitral Transcatheter Edge‐to‐Edge Repair in Patients With Advanced Heart Failure: A Single‐Center Experience and Insights Into Anatomical and Clinical Determinants of Procedural Complexity

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Advanced heart failure (HF) remains a clinical challenge, and mitral transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a potential bridging strategy. Aims To describe the clinical outcomes of M‐TEER in a single‐center cohort of patients with advanced HF and to identify anatomical and clinical features potentially associated ...
Pedro Castilhos de Freitas Crivelaro   +8 more
wiley   +1 more source

From Endothelial Dysfunction to Vascular Occlusion: Role of the Renin-Angiotensin System [PDF]

open access: yes, 2010
There is a body of evidence that supports the important role of the renin-angiotensin system (RAS) in atherosclerotic disease and in the cardiovascular disease continuum: from endothelial dysfunction to vascular occlusion.
Marques da Silva, P
core  

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu   +9 more
wiley   +1 more source

Alterations in the Renin-Angiotensin System in Experimental Septic Shock

open access: yesCritical Care Explorations
OBJECTIVES:. To analyze dynamic changes in the renin-angiotensin system (RAS) during septic shock, focusing on angiotensin-converting enzyme (ACE) activity and the balance between angiotensin peptides, using a mass spectrometry method.
Bruno Garcia, MD, PhD   +11 more
doaj   +1 more source

The Relationship between Apelin and Angiotensin II in Paroxysmal Supraventricular Tachycardia [PDF]

open access: yes
Background: We aimed to investigate apelin and angiotensin II serum levels in patient whit paroxysmal supraventricular tachycardia. Methods: This was a cross-sectional study on 38 patients with paroxysmal supraventricular tachycardia (PSVT), and 38 age-
Ahmad Naghibzadeh, PhD Candidate, Department of Epidemiology AND Physiology Researc   +4 more
core  

Plasma Angiotensin II and the Antihypertensive Action of Angiotensin-Converting Enzyme Inhibition [PDF]

open access: yes, 2017
The measurement of immunoreactive "angiotensin II” in plasma cannot provide an accurate reflection of the efficacy of angiotensin-converting enzyme (ACE) inhibition because different angiotensin fragments interfere in all radioimmunoassays available so ...
Brunner, H. R.   +2 more
core  

Home - About - Disclaimer - Privacy